Caricamento...
Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential
Biologics have changed expectation and outcomes for rheumatoid arthritis (RA). However, the optimal duration and sequence of therapy for this disease has yet to be determined. Also, a significant number of patients do not satisfactorily respond to currently available therapies. The Janus kinase (JAK...
Salvato in:
| Pubblicato in: | Ther Adv Musculoskelet Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5315227/ https://ncbi.nlm.nih.gov/pubmed/28255337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X16687481 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|